Beckman Coulter's assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs ...

The study, funded by the National Institutes of Health, found certain circular RNAs can strongly indicate if symptoms are ...

A recent study indicates that a specific group of blood-based biomarkers known as circular RNAs can help in detecting ...

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

That blood test your doctor suggested to check for Alzheimer’s? It might be giving dramatically different results depending on your race. While these tests promise earlier detection of a devastating ...

The FDA-cleared tests aren’t designed for healthy, symptom-free people, but many people want this information anyway.

The blood draw was an easy proposition. But was I ready for what the result could mean for my family and my future?

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

“I feel like he just dropped a bomb and then left,” Sam Preston said of a doctor telling her she carries the APOE4 gene ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Study reveals a connection between sleep complaints, memory abilities, and Alzheimer’s-related brain changes, but only in ...